V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20217330 | 20131321 | 0 | 78.6 | null | 2018-01-04 | 2018-01-19 | LANREOTIDE | null | null | LANREOTIDE | 100422939 |
| 20217333 | 20131322 | 0 | null | null | 2017-12-07 | 2017-12-10 | LENVATINIB | 02 | null | LENVATINIB | 100638633 |
| 20217338 | 20131323 | 0 | null | null | 2016-12-05 | 2017-01-05 | null | 02 | null | HCX | 100747318 |
| 20217341 | 20131324 | 0 | 78.4 | null | 2016-07-21 | 2016-08-06 | null | N | null | HCX | 101047789 |
| 20217342 | 20131325 | 1.74 | 44 | null | 2019-06-11 | 2019-06-30 | LENVATINIB | 02 | null | LENVATINIB | 100110204 |
| 20217345 | 20131326 | 0 | null | Palliative (P) | null | 2018-07-18 | LANREOTIDE | 99 | N | LANREOTIDE | 100106722 |
| 20217351 | 20131327 | 0 | 77 | Curative (C) | 2018-12-08 | 2018-12-17 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | HCX | 100628140 |
| 20217354 | 20131328 | 1.41 | 113 | null | 2018-03-27 | 2018-04-29 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101143473 |
| 20217360 | 20131329 | 0 | 88.6 | Palliative (P) | null | 2019-01-09 | null | 99 | N | HCX | 100816231 |
| 20217369 | 20131330 | 0 | 84 | Palliative (P) | null | 2019-02-21 | null | null | N | LANREOTIDE | 100902350 |
| 20217374 | 20131331 | 0 | null | Neo-adjuvant (N) | null | 2018-04-24 | null | N | Y | HCX | 101711143 |
| 20217377 | 20131332 | 0 | 52 | null | 2020-04-21 | 2020-05-16 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | null | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101813390 |
| 20217378 | 20131333 | 0 | 128.75 | Palliative (P) | 2017-04-11 | 2017-04-17 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100836377 |
| 20217381 | 20131334 | 0 | null | Disease modification (D) | 2019-02-14 | 2019-10-21 | null | N | N | HCX | 101505873 |
| 20217383 | 20131335 | 0 | 73 | null | null | 2020-02-07 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | HCX | 100818464 |
| 20217385 | 20131336 | 0 | null | null | 2018-06-06 | 2018-06-21 | null | N | null | HCX | 100752207 |
| 20217386 | 20131337 | 0 | 81.5 | Palliative (P) | null | 2018-09-23 | null | 02 | N | DOXORUBICIN EMBOLISATION | 101404860 |
| 20217398 | 20131338 | 0 | 61.6 | Palliative (P) | 2016-04-02 | 2016-04-16 | null | 02 | N | CAPECITABINE + MITOMYCIN | 101847977 |
| 20217399 | 20131339 | 0 | 79.3 | null | 2019-11-09 | 2019-11-09 | Cape+Cisplatin+Trastuzumab Main | N | null | HCX | 100880908 |
| 20217400 | 20131340 | 0 | 81.4 | null | null | 2018-11-08 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101741292 |
| 20217401 | 20131341 | 0 | 87.6 | null | 2019-04-03 | 2019-07-31 | HCX (Cape + Cisp + Tras) - Main | N | null | HCX | 100662830 |
| 20217407 | 20131342 | 1.63 | 0 | null | 2016-05-28 | 2016-07-23 | CAPECITABINE + CISPLATIN + Trastuzumab | N | null | HCX | 101645376 |
| 20217416 | 20131343 | null | null | Palliative (P) | 2017-12-31 | 2018-01-20 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101821000 |
| 20217419 | 20131344 | 0 | 106.3 | null | 2017-08-24 | 2018-07-01 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 100704174 |
| 20217427 | 20131345 | 1.68 | null | null | 2019-06-24 | 2019-07-02 | Cape+Cisplatin+Trastuzumab Main | N | null | HCX | 101680407 |
| 20217438 | 20131346 | 0 | 63 | null | 2016-01-28 | 2016-02-17 | null | 02 | null | HCX | 101489830 |
| 20217439 | 20131347 | 0 | 80 | null | null | 2018-03-29 | Cape+Cisplatin+Trastuzumab Load | 1 | null | HCX | 100767434 |
| 20217451 | 20131348 | 0 | 96 | Palliative (P) | 2020-01-08 | 2020-01-25 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN | 100541659 |
| 20217453 | 20131349 | null | 78 | null | null | 2017-03-20 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN | 101560666 |
| 20217455 | 20131350 | 0 | 72.5 | null | null | 2018-02-14 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100146658 |
| 20217457 | 20131351 | 0 | 108.8 | null | null | 2016-12-10 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101152764 |
| 20217458 | 20131352 | 0 | 70.4 | Palliative (P) | null | 2017-01-06 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100604904 |
| 20217460 | 20131353 | 0 | null | Curative (C) | null | 2019-03-09 | null | 99 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101335390 |
| 20217463 | 20131354 | 0 | null | null | null | 2018-02-24 | HCX (Cape + Cisp + Tras) - Load | 02 | null | HCX | 101373706 |
| 20217466 | 20131355 | null | null | null | null | 2018-08-30 | null | N | null | HCX | 101295900 |
| 20217468 | 20131356 | 0 | null | null | null | 2020-07-09 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101354835 |
| 20217472 | 20131357 | 0 | 113.3 | Palliative (P) | null | 2018-10-11 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101429843 |
| 20217474 | 20131358 | 1.56 | 0 | null | 2017-04-25 | 2017-06-03 | HCX (Cape + Cisp + Tras) - Main | N | null | HCX | 100411057 |
| 20217475 | 20131359 | 1.81 | 0 | null | 2017-08-30 | 2018-03-14 | null | 02 | null | HCX | 100839283 |
| 20217476 | 20131360 | 1.78 | 0 | Palliative (P) | null | 2017-02-22 | null | 02 | N | CAPECITABINE + MITOMYCIN | 101250242 |
| 20217478 | 20131361 | 0 | 81 | Curative (C) | null | 2019-07-16 | Cape+Cisplatin+Trastuzumab Main | N | N | HCX | 100838033 |
| 20217485 | 20131362 | 1.65 | 79 | Palliative (P) | null | 2017-10-04 | null | 02 | N | CAPECITABINE + MITOMYCIN | 100024653 |
| 20217486 | 20131363 | 0 | 76.1 | null | null | 2017-09-07 | LENVATINIB | null | null | LENVATINIB | 100374576 |
| 20217492 | 20131364 | 0 | null | Neo-adjuvant (N) | null | 2019-02-03 | null | 02 | N | LENVATINIB | 100296646 |
| 20217495 | 20131365 | 0 | 91.4 | Palliative (P) | null | 2019-03-06 | FLUOROURACIL + MITOMYCIN | 02 | N | FLUOROURACIL + MITOMYCIN | 101102625 |
| 20217499 | 20131366 | 1.75 | 70 | Curative (C) | 2016-04-17 | 2016-04-22 | null | N | null | HCX | 101163424 |
| 20217507 | 20131367 | 0 | 50.4 | null | 2017-05-16 | 2017-07-21 | null | N | null | HCX | 100064648 |
| 20217511 | 20131368 | 1.73 | 0 | null | 2018-05-23 | 2018-05-31 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 101014940 |
| 20217513 | 20131369 | 0 | 79.4 | Palliative (P) | 2017-08-29 | 2017-10-19 | LENVATINIB | 02 | N | LENVATINIB | 100334636 |
| 20217517 | 20131370 | 0 | 57 | Palliative (P) | null | 2018-01-09 | null | N | null | HCX | 100533196 |